BLSH compared with PACB: revenue, margins and what each company keeps, and the suppliers and customers both name

BLSHBullish

Mkt capRevenueRevenue

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

Compare

BLSHBullish

PACBPacific Biosciences of California, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

BLSHBullish

20.64▼−10.79%

Mkt cap$3.5BRevenue—Revenue—

PACBPacific Biosciences of California, Inc.

2.55▼−0.20%

Regular sessionNov 5 '26

Mkt cap$792.6MRevenue$39MQ2 FY26Revenue$160MFY25

Compare

Regular sessionNov 5 '26

BLSHBullish

PACBPacific Biosciences of California, Inc.

20.64▼−10.79%

Price

2.55▼−0.20%

$3.5B

Mkt cap

$792.6M

—

Revenue

$39MQ2 FY26

—

Revenue

$160MFY25

BLSH20.64▼−10.79%vsPACB2.55▼−0.20%Regular sessionNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

BLSH: latest quarter not drawable. PACB: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BLSH 4

—Deloitte & Touche LLPunlistedsupplier

—BitGounlistedsupplier

—Fireblocksunlistedsupplier

—SPV KYunlistedsupplier

Shared 0

No shared counterparties.

Only PACB 2

—Illumina Cambridgeunlistedsupplier

—Buyerunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

BLSH, solidPACB, dashed